Novartis Opts For Alliance Rather Than Acquisition With Alnylam
Signs RNAi Liver Disease Collaboration
The announcement that the Swiss giant is collaborating again with Alnylam could spark fresh speculation that the firms are moving closer to a merger – or not.
